Status:
ENROLLING_BY_INVITATION
Telerehabilitation in Hemodialysis Patients.
Lead Sponsor:
Hartcentrum Hasselt
Conditions:
Cardiology
Nefrology
Eligibility:
All Genders
Phase:
NA
Brief Summary
Chronic kidney disease is the third most common cause of death, with a prevalence of 10-12%. Patients undergoing hemodialysis often exhibit low levels of physical activity, leading to various health i...
Detailed Description
Chronic kidney disease (CKD) is the third most common cause of death, with a prevalence of 10-12% among men and women. Prior studies indicate that individuals receiving hemodialysis (HD) perform less ...
Eligibility Criteria
Inclusion
- Participants with end-stage renal disease receiving in-center hemodialysis at the frequency of two to three times a week, with each session lasting ≥ 3 h
- Age ≥18 years
- Having signed and dated an informed consent form, indicating that the subject (or a legally-recognized representative) has been informed of all pertinent aspects of the study
- Possession of and/or able to use a smartphone
- Possession of internet connectivity
- Dutch speaking and understanding
- Be clinically stable
- Willing and physically able to follow a technology-supported physical activity intervention and other study procedures in a six months follow-up period
Exclusion
- Orthopedic, neurologic or any other pathologic condition which makes the participant physically unable to technology-supported physical activity intervention and other study procedures in a six months follow-up period
- Cognitive disabilities or mental illnesses
- Any condition which in the opinion of the investigator would make it unsafe or unsuitable for the participant to participate in this study or a life expectancy of less than three months based on investigators judgement
- Participants who were hospitalized at the time of recruitment
- Current or recent participation in other technology-supported programs, even when not directly targeting exercise capacity
Key Trial Info
Start Date :
June 4 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT06891482
Start Date
June 4 2024
End Date
September 1 2025
Last Update
March 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hartcentrum Hasselt
Hasselt, Hasselt, Belgium, 9040